| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Xenon Pharmaceuticals (NASDAQ:XENE) through any online brokerage.
Other companies in Xenon Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Xenon Pharmaceuticals has a consensus price target of $61.28.
The stock price for Xenon Pharmaceuticals (NASDAQ: XENE) is $37.7867 last updated October 5, 2026 at 6:40 PM EDT.
There are no upcoming dividends for Xenon Pharmaceuticals.
Xenon Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Xenon Pharmaceuticals.
Xenon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
